Similar results were observed when different subtypes of breast cancer were studied (ER-positive, ER-negative, HER2-positive, HER2-negative, early-stage, and late-stage) (Figs. 2B–E and 3; Supplementary Figs. 5B-E and 6; and Supplementary Table 5). Here, ERBB2 is linked to breast cancer.